anticancer immunotherapy ctla blockade relies gut microbiota 
antibodies targeting ctla successfully used cancer immunotherapy find antitumor effects ctla blockade depend distinct bacteroides species mice patients tcell responses specific b thetaiotaomicron b fragilis associated efficacy ctla blockade tumors antibiotic-treated germ-free mice respond ctla blockade defect overcome gavage b fragilis immunization b fragilis polysaccharides adoptive transfer b fragilis-specific t cells fecal microbial transplantation humans mice confirmed treatment melanoma patients antibodies ctla favored outgrowth b fragilis anticancer properties study reveals key role bacteroidales immunostimulatory effects ctla blockade 
